(3alpha,4alpha,5beta)-5-(acetyloxy)-15-methoxy-16,19-dioxo-3,4-epoxybufa-14,20,22-trienolide (82793-01-9)

Identification
Name:	(3alpha,4alpha,5beta)-5-(acetyloxy)-15-methoxy-16,19-dioxo-3,4-epoxybufa-14,20,22-trienolide
Synonyms:	Bufa-14,20,22-trienolide, 5-(acetyloxy)-3,4-epoxy-15-methoxy-16,19-dioxo-, (3alpha,4alpha,5beta)-
CAS:	82793-01-9
Molecular Formula:	C₂₇H₃₀O₈
Molecular Weight:	482.5223
InChI:	InChI=1/C27H30O8/c1-14(29)35-27-11-6-16-17(26(27,13-28)10-8-18-24(27)34-18)7-9-25(2)20(15-4-5-19(30)33-12-15)22(31)23(32-3)21(16)25/h4-5,12-13,16-18,20,24H,6-11H2,1-3H3/t16-,17+,18-,20+,24-,25-,26+,27+/m1/s1
Molecular Structure:
Properties
Flash Point:	286.6°C
Boiling Point:	670.4°C at 760 mmHg
Density:	1.36g/cm³
Refractive index:	1.603
Flash Point:	286.6°C
Safety Data

Other Product

Spiro[cyclopentane-1,2'-[9,4](epoxypentadeca[1,11,13]trienimino)[2H]furo[2',3':7,8]naphth[1,2-d]imidazole]-10',26'(9'H)-dione,16'-(acetyloxy)-1',3'-dihydro-5',6',18',20'-tetrahydroxy-14'-methoxy-7',9',15',17',19',21',25'-heptamethyl-,[9'S-(9'R*,12'E,14'R*,15'S*,16'R*,17'S*,18'S*,19'S*,20'R*,21'R*,22'E,24'Z)]-(9CI)
Spiro[cyclohexane-1,2'-[9,4](epoxypentadeca[1,11,- 13]trienimino)[2H]furo[2',3':7,8]naphth[1,2-d]- imidazole]-10',26'(9'H)-dione,16'-(acetyloxy)- 1',3'-dihydro-5',6',18',20'-tetrahydroxy-14'- methoxy-7',9',15',17',19',21',25'-heptamethyl-,(9'S,12'E,14'S,15'R,16'S,17'R,18'R,19'R,20'S,- 21'S,22'E,24'Z)-
(3beta,5beta,6beta)-3-(acetyloxy)-14-hydroxy-19-oxo-5,6-epoxycard-20(22)-enolide
(3alpha,5beta,8xi,9xi)-3-[(4-O-acetyl-6-deoxy-3-O-methyl-beta-D-glycero-hexopyranosyl)oxy]-14-(acetyloxy)card-20(22)-enolide
(3alpha,5beta,8xi,9xi,16beta)-16-(acetyloxy)-3,14-dihydroxycard-20(22)-enolide
1/C21H26N2O4/c1-3-14-8-9-19(25)23(12-14)11-10-16-15-6-4-5-7-18(15)22-20(16)17(13-24)21(26)27-2/h4-7,12,17,22,24H,3,8-11,13H2,1-2H
1/C18H19NO4/c1-22-15-8-11-10(7-13(15)20)5-12-16-9(3-4-19-12)6-14(21)18(23-2)17(11)16/h6-8,12,19-21H,3-5H2,1-2H
(3beta,5beta,11alpha,14xi)-14-(acetyloxy)-3-[(6-deoxy-alpha-L-talopyranosyl)oxy]-5,11-dihydroxy-19-oxocard-20(22)-enolide
(3alpha,5beta,8xi,9xi)-3-(beta-D-glycero-hexopyranosyloxy)-5,14-dihydroxy-19-oxocard-20(22)-enolide
1/C26H18O2/c1-17-16-23-21-9-5-3-7-19(21)11-13-25(23)28-26(17)15-14-22-20-8-4-2-6-18(20)10-12-24(22)27-26/h2-16H,1H
1/C17H16N2O3/c1-9(20)12-8-14-15-11(6-7-19(14)17(22)16(12)21)10-4-2-3-5-13(10)18-15/h2-5,8-9,18,20-21H,6-7H2,1H
1/C18H18O6/c1-22-14-8-13(20)15-16(21)11(9-24-18(15)17(14)23-2)7-10-3-5-12(19)6-4-10/h3-6,8,11,19-20H,7,9H2,1-2H
1/C18H30O4/c1-4-5-6-7-15(19)13-16(20)10-8-14-9-11-17(21-2)18(12-14)22-3/h9,11-12,15-16,19-20H,4-8,10,13H2,1-3H3/t15-,16-/m0/s
1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14
1/C19H15ClN2O2S/c1-11-19(23)24-17-18(25-11)22(2)15-9-8-13(20)10-14(15)16(21-17)12-6-4-3-5-7-12/h3-11H,1-2H
1/C17H22N6/c1-2-8-19-13-11-14(23-10-9-18-12-23)20-16-15(13)21-17(22-16)6-4-3-5-7-17/h9-12,19H,2-8H2,1H
1/C19H24N2O2/c1-12(2)14-8-6-9-15(13(3)4)17(14)21-19(22)18-16(23-5)10-7-11-20-18/h6-13H,1-5H3,(H,21,22
1/C20H20N2/c1-4-10-16(11-5-1)18-19(17-12-6-2-7-13-17)22-20(21-18)14-8-3-9-15-20/h1-2,4-7,10-13H,3,8-9,14-15H
Bufa-3,20,22-trienolide,16-(acetyloxy)-5-(b-D-glucopyranosyloxy)-14-hydroxy-19-oxo-, (5b,16b)- (9CI)
(3beta,5beta)-3-({[(4alpha,16xi,17R,21alpha)-17,21-dihydroxyajmalan-4-ium-4-yl]acetyl}oxy)-5,14-dihydroxy-19-oxocard-20(22)-enolide bromide